A catalogue of new incidence estimates of monogenic neurodevelopmental disorders caused by de novo variants
- PMID: 32168371
- PMCID: PMC7174049
- DOI: 10.1093/brain/awaa051
A catalogue of new incidence estimates of monogenic neurodevelopmental disorders caused by de novo variants
Abstract
A large fraction of rare and severe neurodevelopmental disorders are caused by sporadic de novo variants. Epidemiological disease estimates are not available for the vast majority of these de novo monogenic neurodevelopmental disorders because of phenotypic heterogeneity and the absence of large-scale genomic screens. Yet, knowledge of disease incidence is important for clinicians and researchers to guide health policy planning. Here, we adjusted a statistical method based on genetic data to predict, for the first time, the incidences of 101 known de novo variant-associated neurodevelopmental disorders as well as 3106 putative monogenic disorders. Two corroboration analyses supported the validity of the calculated estimates. First, greater predicted gene-disorder incidences positively correlated with larger numbers of pathogenic variants collected from patient variant databases (Kendall's τ = 0.093, P-value = 6.9 × 10-6). Second, for six of seven (86%) de novo variant associated monogenic disorders for which epidemiological estimates were available (SCN1A, SLC2A1, SALL1, TBX5, KCNQ2, and CDKL5), the predicted incidence estimates matched the reported estimates. We conclude that in the absence of epidemiological data, our catalogue of 3207 incidence estimates for disorders caused by de novo variants can guide patient advocacy groups, clinicians, researchers, and policymakers in strategic decision-making.
Keywords: autism; epilepsy; incidence; neurodevelopmental disorder.
© The Author(s) (2020). Published by Oxford University Press on behalf of the Guarantors of Brain.
Figures

Comment in
-
Predicting incidences of neurodevelopmental disorders.Brain. 2020 Apr 1;143(4):1046-1048. doi: 10.1093/brain/awaa079. Brain. 2020. PMID: 32318731 No abstract available.
Similar articles
-
Common genetic variants contribute to risk of rare severe neurodevelopmental disorders.Nature. 2018 Oct;562(7726):268-271. doi: 10.1038/s41586-018-0566-4. Epub 2018 Sep 26. Nature. 2018. PMID: 30258228 Free PMC article.
-
De novo variants in neurodevelopmental disorders-experiences from a tertiary care center.Clin Genet. 2021 Jul;100(1):14-28. doi: 10.1111/cge.13946. Epub 2021 Mar 1. Clin Genet. 2021. PMID: 33619735
-
Large-scale discovery of novel neurodevelopmental disorder-related genes through a unified analysis of single-nucleotide and copy number variants.Genome Med. 2022 Apr 26;14(1):40. doi: 10.1186/s13073-022-01042-w. Genome Med. 2022. PMID: 35468861 Free PMC article.
-
The Role of De Novo Noncoding Regulatory Mutations in Neurodevelopmental Disorders.Trends Neurosci. 2019 Feb;42(2):115-127. doi: 10.1016/j.tins.2018.11.002. Epub 2018 Dec 15. Trends Neurosci. 2019. PMID: 30563709 Free PMC article. Review.
-
Neurodevelopmental disorder associated with de novo SCN3A pathogenic variants: two new cases and review of the literature.Brain Dev. 2020 Feb;42(2):211-216. doi: 10.1016/j.braindev.2019.09.004. Epub 2019 Oct 31. Brain Dev. 2020. PMID: 31677917 Review.
Cited by
-
Generation of humanized mouse models to support therapeutic development for SYNGAP1 and STXBP1 disorders.bioRxiv [Preprint]. 2024 Aug 22:2024.08.22.609238. doi: 10.1101/2024.08.22.609238. bioRxiv. 2024. PMID: 39229131 Free PMC article. Preprint.
-
Clinical and genetic analysis of 23 Chinese children with epilepsy associated with KCNQ2 gene mutations.Epilepsia Open. 2024 Oct;9(5):1658-1669. doi: 10.1002/epi4.13028. Epub 2024 Aug 14. Epilepsia Open. 2024. PMID: 39141400 Free PMC article.
-
Estimating the Prevalence of De Novo Monogenic Neurodevelopmental Disorders from Large Cohort Studies.Biomedicines. 2022 Nov 9;10(11):2865. doi: 10.3390/biomedicines10112865. Biomedicines. 2022. PMID: 36359385 Free PMC article.
-
Patterns of developmental regression and associated clinical characteristics in SLC6A1-related disorder.Front Neurosci. 2023 Feb 21;17:1024388. doi: 10.3389/fnins.2023.1024388. eCollection 2023. Front Neurosci. 2023. PMID: 36895422 Free PMC article.
-
Natural History Study of STXBP1-Developmental and Epileptic Encephalopathy Into Adulthood.Neurology. 2022 Jul 19;99(3):e221-e233. doi: 10.1212/WNL.0000000000200715. Epub 2022 Jun 3. Neurology. 2022. PMID: 35851549 Free PMC article.
References
-
- Auvin S, Irwin J, Abi-Aad P, Battersby A.. The problem of rarity: estimation of prevalence in rare disease. Value Health 2018; 21: 501–7. - PubMed
-
- Bayat A, Hjalgrim H, Moller RS.. The incidence of SCN1A-related Dravet syndrome in Denmark is 1:22,000: a population-based study from 2004 to 2009. Epilepsia 2015; 56: e36–9. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous